We are live on ! Find out more
VRX

VALEANT PHARMACEUTICALS INTL
VRX

Delisted

VRX was delisted on the 27th of September, 2010.

Back to rankings

1 hedge funds and large institutions have $657K invested in VALEANT PHARMACEUTICALS INTL in 2014 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $669K → $657K (-$12K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LWI
Long Wharf Investors
Massachusetts
+$17K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LWI
1
Long Wharf Investors
Massachusetts
$657K +$17K +135 +3%

VRX Hedge Fund Activity: Q2 2014 in Review

1 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in VALEANT PHARMACEUTICALS INTL (VRX) for Q2 2014, worth a combined $657K — down 1.8% from $669K a quarter earlier.

Fund positioning in VRX was balanced in Q2 2014: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Long Wharf Investors, adding an estimated $17K.

  • 1 institutional investor held VALEANT PHARMACEUTICALS INTL (VRX) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $657K of VALEANT PHARMACEUTICALS INTL stock for Q2 2014, down 1.8% quarter-over-quarter.
  • 0 funds opened new VALEANT PHARMACEUTICALS INTL positions in Q2 2014 and 0 closed out.
  • The largest VALEANT PHARMACEUTICALS INTL buyer in Q2 2014 was Long Wharf Investors, an estimated $17K added.

Based on aggregated 13F filings for Q2 2014.